Close
Home News Page 417

News

This section brings in the latest news and the headlines in the Pharmaceutical industry. Our dedicated news team closely observes the Pharma Industry and keeps you updated of latest developments across the world.

Lilly Announces New Vice President of Oncology Research


Eli Lilly and Company announced that Greg Plowman, M.D., Ph.D., will lead Lilly's oncology research...

AstraZeneca initiates phase III clinical programme evaluating NKTR-118


AstraZeneca announced enrolment of the first patient in the Phase III clinical programme for NKTR-118,...

Takeda’s Donation to Aid Earthquake Relief Efforts in Japan


Takeda Pharmaceutical Company Limited announced 300 million Japanese yen donation to aid emergency relief for...

Amgen Donates $1 Million to Help Japanese Disaster Victims


Amgen announced that the company will donate $1 million to Japanese disaster relief efforts. Amgen...

Bristol-Myers Squibb Foundation Announces Funding of Nearly $1 Million to China & India


The Bristol-Myers Squibb Foundation has awarded four new grants to help improve awareness, prevention and...

Pfizer Completes Acquisition Of King Pharmaceuticals, Inc.


Pfizer Inc. announced that it has combined operations with King Pharmaceuticals, Inc. On February 28,...

Pharma Idol Winner Announced


Since launching in November, eyeforpharma's Pharma Idol competition has caused quite a stir in the...

Caldolor® Rapid Infusion Shown to be Safe and Well Tolerated


Cumberland Pharmaceuticals Inc.announced the publication of data from a clinical trial evaluating the pharmacokinetics, safety...

BioSante Pharmaceuticals, Inc. To Present LibiGel® Safety Study Update At BIO CEO & Investor...


BioSante Pharmaceuticals, Inc. will be presenting at the 2011 BIO CEO & Investor Conference. Hosted...

First African country introduces GSK’s pneumococcal vaccine through innovative financing mechanism


GlaxoSmithKline (GSK) announced the incorporation of its pneumococcal vaccine into the Kenyan national immunisation programme. ...